Novo Nordisk | Marketskapitalisme



Market Capitalization Endring Dato
ANI Pharmaceuticals USD 1.16B 95M 2024-12
Aurora Cannabis CAD 335.3M 101.41M 2024-12
Bristol-Myers Squibb USD 114.71B 9.82B 2024-12
Canopy Growth CAD 612.33M 169.68M 2024-12
Corcept Therapeutics USD 5.28B 444M 2024-12
Eli Lilly USD 732.87B 109.15B 2024-12
GlaxoSmithKline GBP 55.81B 7.05B 2024-12
Merck USD 251.65B 36.21B 2024-12
Novartis CHF 194.25B 18.5B 2024-12
Novo Nordisk A/S 2.12T 551.23B 2024-12
Pacira USD 870M 176M 2024-12
Perrigo USD 3.51B 70M 2024-12
Prestige Brands USD 3.86B 285M 2024-12
Sanofi EUR 118.41B 10.58B 2024-12
Supernus Pharmaceuticals USD 2.02B 294M 2024-12



Novo Nordisk Marketskapitalisme - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.